Application 018423
- Type
- NDA
- Sponsor
- MOLNLYCKE HLTH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HIBICLENS | CHLORHEXIDINE GLUCONATE | SPONGE;TOPICAL | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018423-001 | HIBICLENS | CHLORHEXIDINE GLUCONATE | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE / TOPICAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N018423-001 | HIBICLENS | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE / TOPICAL | RLD, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N018423-001 | HIBICLENS | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE / TOPICAL | RLD, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N018423-001 | HIBICLENS | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE / TOPICAL | RLD, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N018423-001 | HIBICLENS | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPONGE / TOPICAL | RLD, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.